InsidersTradesSigma
Declaraciones totales
Empresas
▲ Compras (0 oper.)
▼ Ventas (6 oper.)
Historial del iniciado
Director FinancieroCompras declaradas
0
Ventas declaradas
6
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Discover the detailed record of transactions filed by Daskal Ilan, Director Financiero. Insider active across 4 companies, notably Natus Medical INC. Aggregated, 25 filings have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €3.1m. History available since 11 June 2021. The latest transaction was disclosed on 28 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Daskal Ilan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones25 en total
55.114 títulos0Common StockSEC:0000912093-26-000072:0
24.857 títulos@ 36,54 US$Common StockSEC:0000912093-26-000072:1
47.420 títulos0Common StockSEC:0000912093-26-000072:2
21.387 títulos@ 36,54 US$Common StockSEC:0000912093-26-000072:3
30.257 títulos@ 36,29 US$Common StockSEC:0000912093-26-000074:0
26.033 títulos@ 36,29 US$Common StockSEC:0000912093-26-000074:1
25.100 títulos@ 17,84 US$36.6% de su flujoCommon StockSEC:0000912093-25-000213:0
62.645 títulos0Common StockSEC:0000912093-25-000207:0
70.545 títulos0Common StockSEC:0000912093-25-000129:0
55.115 títulos0Common StockSEC:0000912093-25-000102:0
82.095 títulos@ 9,28 US$100.0% de su flujoCommon StockSEC:0000912093-25-000075:0
39.783 títulos0Common StockSEC:0001127602-24-028243:0
694 títulos0Bio-Rad A Common StockSEC:0001062993-23-017644:0
243 títulos@ 466,24 US$6.2% de su flujoBio-Rad A Common StockSEC:0001062993-23-009008:1
700 títulos0Bio-Rad A Common StockSEC:0001062993-23-009008:0
541 títulos0Bio-Rad A Common StockSEC:0001062993-22-019274:0
455 títulos0Bio-Rad A Common StockSEC:0001062993-22-019183:0
18.937 títulos@ 33,50 US$63.0% de su flujoCommon Stock, $0.001 par value per shareSEC:0000878526-22-000092:0
5075 títulos0Common Stock, $0.001 par value per shareSEC:0000878526-22-000041:0
700 títulos0Bio-Rad A Common StockSEC:0001062993-22-010014:0
270 títulos@ 820,06 US$20.8% de su flujoBio-Rad A Common StockSEC:0001062993-21-008354:0
540 títulos@ 524,30 US$26.6% de su flujoBio-Rad A Common StockSEC:0001062993-21-008242:0
1400 títulos@ 309,84 US$40.9% de su flujoBio-Rad A Common StockSEC:0001062993-21-007078:0
5214 títulos@ 28,77 US$15.7% de su flujoCommon Stock, $0.001 par value per shareSEC:0000878526-21-000061:0
2500 títulos@ 27,46 US$7.0% de su flujoCommon Stock, $0.001 par vale per shareSEC:0000878526-21-000053:0
25 de 25 declaraciones
About Daskal Ilan
Daskal Ilan is Directeur Financier. He has filed 19 disclosures in total. Across the 19 most recent sampled filings, they cover the period from 2021-06-15 to 2025-12-03, with 0 in purchases and 1916256 in sales, and the most frequent transaction nature is Levée d'options. His listed companies are Bio-Rad Laboratories, INC., where he is EVP, Chief Financial Officer, Viavi Solutions INC., where he is EVP, CFO, and Natus Medical INC, where he is Director.
